Loading insider details...
Latest Form 4 (Jun 18, 2026): Grant/Award of 50,000 FDMT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 50,000 | n/a |
| Jun 11, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 70,000 | n/a |
| Jun 20, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Jun 12, 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 62,728 | n/a |
| Oct 22, 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Purchase | 413 | $5.3K |
| Jun 6, 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 40,282 | n/a |
| May 23, 2024 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Jul 5, 2023 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 21,222 | n/a |
| May 25, 2023 | 4D Molecular Therapeutics, Inc. (FMDT) | Grant/Award | 22,500 | n/a |
| Jun 9, 2022 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 53,812 | n/a |